Literature DB >> 21506191

Should Medicare adopt the Veterans Health Administration formulary?

Austin B Frakt1, Steven D Pizer, Roger Feldman.   

Abstract

Since January 2006 all Medicare beneficiaries have been eligible to obtain outpatient prescription drug coverage through private stand-alone drug plans (PDPs). We estimate a model of beneficiary demand for PDPs and use it to compute the loss of consumer surplus due to tightening PDP formularies to the level found in the Veterans Health Administration (VA). Under a generous assumption of cost savings attributed to increased bargaining leverage associated with exclusion of more drugs from formularies, we find the loss in consumer surplus to be smaller than the financial savings that could be shared between Medicare and beneficiaries. According to our estimates, Medicare beneficiaries could be compensated for the loss in consumer surplus associated with tighter PDP formularies with the savings generated by such formularies.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506191     DOI: 10.1002/hec.1733

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  9 in total

1.  The doughnut hole: it's about medication adherence.

Authors:  Christianne L Roumie
Journal:  Ann Intern Med       Date:  2012-06-05       Impact factor: 25.391

2.  Medicare part D prescription drug program: benefits, unintended consequences and impact on health disparities.

Authors:  Clara E Dismuke; Leonard E Egede
Journal:  J Gen Intern Med       Date:  2013-07       Impact factor: 5.128

3.  Guideline-concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D.

Authors:  Nicolae Done; Amanda M Roy; Yingzhe Yuan; Steven D Pizer; Adam J Rose; Julia C Prentice
Journal:  Health Serv Res       Date:  2018-11-11       Impact factor: 3.402

4.  Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.

Authors:  Jagpreet Chhatwal; Fasiha Kanwal; Mark S Roberts; Michael A Dunn
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

5.  A Prescription for Drug Formulary Evaluation: An Application of Price Indexes.

Authors:  Jacob Glazer; Haiden A Huskamp; Thomas G McGuire
Journal:  Forum Health Econ Policy       Date:  2012-03-30

6.  Health care for patients with serious mental illness: family medicine's role.

Authors:  Nancy E Morden; Lisa A Mistler; William B Weeks; Stephen J Bartels
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

7.  Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison.

Authors:  Walid F Gellad; Julie M Donohue; Xinhua Zhao; Maria K Mor; Carolyn T Thorpe; Jeremy Smith; Chester B Good; Michael J Fine; Nancy E Morden
Journal:  Ann Intern Med       Date:  2013-07-16       Impact factor: 25.391

8.  Paying for Drugs After the Medicare Part D Beneficiary Reaches the Catastrophic Limit: Lessons on Cost Sharing from Other US Policy Partnerships Between Government and Commercial Industry.

Authors:  William V Padula; Jeromie Ballreich; Gerard F Anderson
Journal:  Appl Health Econ Health Policy       Date:  2018-12       Impact factor: 2.561

9.  Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses.

Authors:  Christopher Cai; Jackson Runte; Isabel Ostrer; Kacey Berry; Ninez Ponce; Michael Rodriguez; Stefano Bertozzi; Justin S White; James G Kahn
Journal:  PLoS Med       Date:  2020-01-15       Impact factor: 11.069

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.